Synthesis, Crystal Structure and Biological Characterization of a Novel Palladium(II) Complex with a Coumarin‐Derived Ligand

Methyl 2-methyl-4-oxo-4H-chromene-3-carboxylate (1) was treated with 25% aqueous ammonia to give 3-(1-aminoethylidene)-2H-chromene-2,4(3H)-dione (2). Compound 2 was used as a ligand for the formation of a palladium(II) complex. The structures of the ligand and its palladium complex 3 were determined by IR and 1H NMR spectroscopy, FAB mass spectrometry and elemental analysis. The single-crystal X-ray structure of 3 was also solved. Ligand 2 in 20% dioxane solution shows two protonation constants — log β11 = 4.28 ± 0.01 and log β12 = 7.66 ± 0.03. In complex 3 two ligand molecules chelate to the Pd ion through their N and O donors, giving a four-coordinate PdII center with a cis-N2O2 donor set. The coordination geometry at PdII is square-planar with typical values for the distances from the Pd atom to the coordinated atoms. The cytotoxicity of compound 3 was determined on three cancer cell lines. IC50 values of 9.7, 7.8 and 7.8 nM were found for A546, HeLa and K562 cells, respectively, which is notably lower than carboplatin, which shows corresponding IC50 values of 105.98, 73.49 and 60.92 μM. Double-stranded DNA treated with 3 shows a significant increase in the Δϵ value in the CD spectra, as well as a lower electrophoretic mobility than parent DNA. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004)

[1]  S. J. Grabowski,et al.  Crystal and molecular structures of 3-[1-(2-hydroxyethylamino)-ethylidene]-chroman-2,4-dione and 2-methoxy-3-[1-(benzylamino)-ethylidene]-2,3-dihydro-2,4-dioxo-2λ5-benzo[e][1,2]oxaphosphinane and DFT study of intramolecular H-bonds of related compounds , 2004 .

[2]  M. Różalski,et al.  Cytotoxic effects, alkylating properties and molecular modelling of coumarin derivatives and their phosphonic analogues. , 2003, European journal of medicinal chemistry.

[3]  E. Nawrot,et al.  Synthesis, antimicrobial, and alkylating properties of 3‐phosphonic derivatives of chromone , 2001, Archiv der Pharmazie.

[4]  B. J. Kim,et al.  Classification of CD and absorption spectra in the Soret band of H(2)TMPyP bound to various synthetic polynucleotides. , 2001, Biophysical chemistry.

[5]  M. Małecka,et al.  Investigations on benz[1,2]oxaphosphinane derivatives. , 2001, Acta crystallographica. Section C, Crystal structure communications.

[6]  I. Kostova,et al.  Synthesis, Physicochemical Characterization, and Cytotoxic Screening of New Zirconium Complexes with Coumarin Derivatives , 2001, Archiv der Pharmazie.

[7]  Mohamed R. Shehata,et al.  Mixed ligand complexes of diaquo (2,2′-bipyridine)palladium(II) with cyclobutane-1,1-dicarboxylic acid and DNA constituents , 2001 .

[8]  T. Netzeva,et al.  Cytotoxic Activity of Cerium Complexes with Coumarin Derivatives. Molecular Modeling of the Ligands , 2000, Archiv der Pharmazie.

[9]  S. Rajski,et al.  DNA Cross-Linking Agents as Antitumor Drugs. , 1998, Chemical reviews.

[10]  L. Rashan,et al.  Synthesis and cytotoxic evaluation of the first trans-palladium(II) complex with naturally occurring alkaloid harmine , 1998 .

[11]  R. Fawzi,et al.  Chemical properties and cytotoxic activity of complexes of platinum(II) and palladium(II) containing dmso and various anions; synthesis and structural characterization of [Pt(dmso)2{O2(CO)2CCH2CH2CH2}] , 1998 .

[12]  J. Perez,et al.  Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA. , 1998, Journal of medicinal chemistry.

[13]  C. Siegers,et al.  Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. , 1998, Research communications in molecular pathology and pharmacology.

[14]  E. De Clercq,et al.  Palladium(II) complexes of dialkyl alpha-Anilinobenzylphosphonates. Synthesis, characterization, and cytostatic activity. , 1996, Journal of inorganic biochemistry.

[15]  P. Sohár,et al.  Tricarbonylmethane acylhydrazones: Reactions under acylating conditions and formation of fused isoxazole derivatives with concomitant NN bond cleavage , 1995 .

[16]  S. Fricker,et al.  Synthesis and cytotoxicity of some cyclometallated palladium complexes. , 1993, Journal of inorganic biochemistry.

[17]  M. F. Richardson,et al.  Palladium and platinum complexes with vitamin B6 compounds , 1992 .

[18]  P. Gans,et al.  Mathematical algorithms and computer programs for the determination of equilibrium constants from potentiometric and spectrophotometric measurements , 1992 .

[19]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[20]  D. Lydall,et al.  Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. , 1986, Cancer research.

[21]  P. Loehrer,et al.  Drugs five years later. Cisplatin. , 1984, Annals of internal medicine.

[22]  G. Coppola,et al.  An Improved Synthesis of 2-Methylchromone-3-carboxylic Acid and Its Esters , 1981 .

[23]  J. Trosko,et al.  Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.

[24]  S. Kirschner,et al.  Anticancer and potential antiviral activity of complex inorganic compounds. , 1966, Journal of medicinal chemistry.

[25]  I. Levine Structure of Formaldoxime , 1963 .

[26]  M. Jakupec,et al.  Tumour-inhibiting platinum complexes--state of the art and future perspectives. , 2003, Reviews of physiology, biochemistry and pharmacology.

[27]  G. Mazur,et al.  Comparison of pharmacological and clinical activity between cisplatin and carboplatin in the treatment of solid tumours , 2000 .

[28]  I. Kostova,et al.  Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Warfarin and Coumachlor sodium salts , 1999 .

[29]  J. Reedijk Improved understanding in platinium antitumour chemistry , 1996 .

[30]  B. Keppler Metal complexes in cancer chemotherapy , 1993 .

[31]  R. Ratliff,et al.  Circular dichroism spectroscopy of DNA. , 1992, Methods in enzymology.

[32]  L. Rashan,et al.  Synthesis and characterization of novel biologically active platinum(II) and palladium(II) complexes of some β-carboline alkaloids , 1990 .

[33]  L. Pettit,et al.  Complex formation between palladium(II) and amino acids, peptides and related ligands , 1985 .

[34]  J. Reedijk,et al.  Coordination compounds of Pt(II) and Pd(II) with imidazole as a ligand. New synthetic procedures and characterization , 1979 .

[35]  G. D. Rieck,et al.  International tables for X-ray crystallography , 1962 .